Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “vildagliptin”
Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00120536. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00101803. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099853. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)
ClinicalTrials.gov study NCT01582308. IPD Sharing: YES. Countries: 0. Publications: 1.
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138515. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone
ClinicalTrials.gov study NCT00396227. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099944. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01224366. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance
ClinicalTrials.gov study NCT00237250. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.
ClinicalTrials.gov study NCT01649466. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
ClinicalTrials.gov study NCT01262586. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Figure 1 from: Mohamed AA, Hamed HE, Rahi FA (2024) Formulation, characterization and evaluation of vildagliptin and metformin combined tablets. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e117712
Figure 1 HPLC of MET and VD at a retention time of 2.194 and 3.945 min, respectively, for 500 µg/ml and 50 µg/ml. Conditions: a CN (5 μm, 25 cm × 4.6 mm) column and 25% Acetonitrile: 75% Buffer pH (3.0) as the mobile phase were detected at 254 and 203 nm.
Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
ClinicalTrials.gov study NCT02007278. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin
ClinicalTrials.gov study NCT01766778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00351585. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Vildagliptin Versus Dapagliflozin on Glucagon
ClinicalTrials.gov study NCT02475070. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy
ClinicalTrials.gov study NCT01811485. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes
ClinicalTrials.gov study NCT01882907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function
ClinicalTrials.gov study NCT01686932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyro
ClinicalTrials.gov study NCT02862470. IPD Sharing: NO. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.